BUZZ-Ultragenyx up after US FDA approves gene therapy
RARE•FDA approval lifts Ultragenyx shares
** Ultragenyx Pharmaceutical RARE.O shares rise 7.3% to $13.84
** U.S. Food and Drug Administration has approved Ultragenyx's gene therapy for the treatment of a rare, fatal disease
** Including session gains, stock has fallen ~40% YTD
